Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.325 USD | -0.21% | -2.65% | +1.49% |
May. 30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
May. 30 | Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise | MT |
Financials (USD)
Sales 2024 * | 185M | Sales 2025 * | 220M | Capitalization | 345M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -31M | EV / Sales 2024 * | 1.87 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
-5.59
x | P/E ratio 2025 * |
-10.9
x | Employees | 377 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.09% |
Latest transcript on Xeris Biopharma Holdings, Inc.
1 day | -0.21% | ||
1 week | -2.65% | ||
Current month | +5.76% | ||
1 month | +35.51% | ||
3 months | +6.00% | ||
6 months | +24.22% | ||
Current year | +1.49% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Edick
CEO | Chief Executive Officer | 67 | 21-04-30 |
Steven Pieper
DFI | Director of Finance/CFO | 47 | 21-09-30 |
John Shannon
PSD | President | 62 | 21-10-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Johnson
BRD | Director/Board Member | 66 | 21-10-04 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 21-10-04 |
Marla Persky
BRD | Director/Board Member | 68 | 21-10-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 2.375 | +1.93% | 282 457 |
24-06-07 | 2.33 | -1.27% | 1,811,302 |
24-06-06 | 2.36 | -2.88% | 959,299 |
24-06-05 | 2.43 | +4.74% | 1,747,746 |
24-06-04 | 2.32 | -5.31% | 1,849,224 |
Delayed Quote Nasdaq, June 10, 2024 at 09:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.49% | 345M | |
+47.08% | 765B | |
-6.11% | 354B | |
+20.09% | 331B | |
+8.84% | 299B | |
+18.92% | 248B | |
-1.68% | 219B | |
+11.06% | 216B | |
+5.54% | 164B | |
-2.80% | 162B |
- Stock Market
- Equities
- XERS Stock